Page last updated: 2024-09-03

pramipexole and Opioid-Related Disorders

pramipexole has been researched along with Opioid-Related Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Escalona, R; Laubenthal, CE; Welch, JE1
Escalona, R; Fawcett, J; Rush, AJ1
Caine, SB; Everitt, BJ; Koob, GF; Parsons, LH; Schwartz, JC; Sokoloff, P1

Other Studies

3 other study(ies) available for pramipexole and Opioid-Related Disorders

ArticleYear
Rapid Treatment of Anhedonia With Pramipexole as Adjunct to Buprenorphine in Opioid Use Disorder.
    The primary care companion for CNS disorders, 2023, 10-26, Volume: 25, Issue:5

    Topics: Anhedonia; Buprenorphine; Humans; Narcotic Antagonists; Opioid-Related Disorders; Pramipexole

2023
Pramipexole Augmentation of Buprenorphine Improves Pain and Depression in Opioid Use Disorder: A Case Report.
    The primary care companion for CNS disorders, 2020, Oct-15, Volume: 22, Issue:5

    Topics: Analgesics, Opioid; Buprenorphine; Depression; Humans; Opioid-Related Disorders; Pain; Pramipexole

2020
D3 receptor test in vitro predicts decreased cocaine self-administration in rats.
    Neuroreport, 1997, Jul-07, Volume: 8, Issue:9-10

    Topics: Animals; Benzopyrans; Benzothiazoles; Cocaine; Dopamine Agonists; Dopamine Antagonists; In Vitro Techniques; Male; Naphthalenes; Opioid-Related Disorders; Oxazines; Pramipexole; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Self Administration; Thiazoles

1997